animal watch
applied academics with annie
arts & culture
book talk
bridging the achievement gap
editorial
education
energy/environment
financial literacy
geography
health
history
news
our favorite quotes
science
science and technology
space science
special features
sports
stories from the south side
where in dane county?
wisconsin museums
our student bios
animal watch
energy/environment
geography
health
history
news
poems
science and technology
science
space science
sports
animal watch
energy and the environment
health
history
science
space science
subscribe
advertise
sponsor
join the red rack express club!
become a friend of the Free Press
Friends List
SSFP in the News
Testimonials
Friday, April 25, 2014 home site map printer-friendly

FDA Blocks Sale of Personal Genetics Tests

by Stephanie Sykes, age 18

The Food and Drug Administration (FDA) recently blocked the sale of the first over-the-counter personal genetics tests. This product was scheduled to hit the shelves of Walgreens and CVS pharmacies this year. Many would have been thrilled with this opportunity to test their likelihood of developing genetic diseases. The FDA, however, certainly wasn’t jumping for joy.

The test’s manufacturer, Pathway Genetics, had their distribution plan set earlier this summer. Almost immediately after, the FDA announced that they did not consider the test a legitimate medical tool.

Consumers who chose to buy the test kit would have spent between $20 and $30 to purchase a vial in which they could collect their own saliva to send to Pathway Genomics. For additional costs of between $79 and $249, Pathway would have provided an in-depth analysis of the customer’s genetic code for pre-pregnancy planning and health condition analysis.

Tests like this one are nothing new. Doctors and other healthcare professionals have purchased similar products online for years. Online companies similar to Pathway Genomics currently market genetics tests to consumers online. The cost is usually between from $400 and $1,000.

The FDA is concerned about these new over-the-counter tests because they eliminate the involvement and supervision of a medical professional. A direct-to-patient set up could lead to inaccurate test results and misinterpretations of data. They don’t want people to self-diagnose, or worse, take decisions about drug dosage into their own hands.

The FDA is also unsure of how accurate the test results are, and they plan to continue to block retail sale of this new product. Walgreens claims it is simply trying to satisfy the consumer demand. They want to sell the tests at 6,000 of their 7,500 stores.

[Sources: Chicago Sun Times; Associated Press]

Stephanie,

I thrilled you chose to cover this topic. This was an incredibly powerful and controversial legislative decision. I think that the FDA made a responsible and necessary decision. Genetic testing is an incredibly sensitive topic--as far as how it is measured and discussed. It would be unethical to allow people to discover they have very high risk for seriously devastating diseases (like Huntington's for example) while offering no to little social or emotional support. Furthermore, genetic testing generally involves highly sophisticated technology, the suggestion that equally valid testing is available for $30 is beyond doubtful. – Andrea L. GilmoreMadison, WI (2010-11-20 15:52)
Name
Location
Email
Comment
Please enter the word shown below (reduces spam).
captcha
Click the image to generate a new one.